Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding and cardiac arrest among patients with atrial fibrillation. The CABANA randomized clinical trial
Douglas L. Packer, Daniel B. Mark, Richard A. Robb, Kristi H. Monahan, Tristram D. Bahnson, Jeanne E. Poole, Peter A. Noseworthy, Yves D. Rosenberg, Neal Jeffries, L. Brent Mitchell, Greg C. Flaker, Evgengy Pokushalov, Alexander Romanov, T. Jared Brunch, George Noelker, Andrey Ardashev, Amiran Revishvili, David J. Wilber, Riccardo Cappato, Karl-Heinz Kuck, Gerhard Hindricks, D. Wyn Davies, Peter R. Kowey, Gerald V. Naccarelli, James A. Reiffel, Jonathan P. Piccini, Adam P. Silverstein, Hussein R. Al-Khalidi, Kerry L. Lee for the CABANA Investigators
Entrevistado: Diogo Magalhães Cavaco
Entrevistador: Ricardo Fontes-Carvalho
Link: ht***tps://www.youtube.com/watch?v=t4_HvOtyUbQ&feature=youtu.be
Conflicts of interest”The authors have no conflicts of interest to declare.”
Please cite this article as: Brief Comment Video to the Recommended Article of the Month. Rev Port Cardiol. 2019;38:389.
